| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |